Innovent, Lilly ink pact for novel drugs
Researchers seen at a lab of Innovent Biologics in Suzhou, Jiangsu province. YANG HAISHI/FOR CHINA DAILY Innovent Biologics has entered into a strategic collaboration with US pharmaceutical giant Eli Lilly and Company to jointly advance novel medicines in oncology and immunology, a deal that reflects the growing integration of leading Chinese biopharmaceutical companies into the…









